Skip to main content
Explore URMC
menu

Mark B. Taubman, M.D.

Contact Information

Phone Numbers

Administrative: (585) 275-3407

Office: (585) 275-3407

Fax: (585) 273-1059

URMFGA member of the University of Rochester Medical Faculty Group

groupAn Accountable Health Partner

assignmentNot Accepting New Patients

Faculty Appointments

  • Professor - Department of Medicine , Cardiology (SMD)
  • CEO, University of Rochester Medical Center - Office of VP for Health Sciences (URMC)
  • Dean, School of Medicine & Dentistry - Dean's Office, SMD (SMD)

Patient Care Setting

Cardiology

Biography

Dr. Mark Taubman serves as the Charles A. Dewey Professor and Chairman of Medicine at the University of Rochester School of Medicine and Dentistry. He is certified by the American Board of Internal Medicine in both Internal Medicine and Cardiovascular Disease.

Dr. Taubman received his medical degree at the New York University School of Medicine. He completed his residency in Internal Medicine at Brigham & Women's Hospital in Boston, Massachusetts, and completed fellowships in Cardiology at Brigham & Women's Hospital and Boston Children's Hospital. Prior to coming to the University of Rochester, Dr. Taubman served as Professor of Medicine at the Mount Sinai School of Medicine in New York City

Professional Background

Dr. Taubman is CEO of the Medical Center, Dean of the School of Medicine and Dentistry, and Senior Vice President for Health Sciences at the University of Rochester. He received his M.D. degree from New York University and completed his training in medicine and cardiology at the Brigham and Women's Hospital and Harvard Medical School. He has served on the faculties of Mt. Sinai School of Medicine in New York, Children's Hospital Medical Center and Harvard Medical School in Boston, Massachusetts. Dr. Taubman was previously the Charles E. Dewey Professor and Chairman of Medicine (2007-2010) and Chief of the Cardiology Division (2003-2009) at the University of Rochester. In addition he was Director of the Aab Cardiovascular Research Institute (2005-2007) and Director of the Center for Cellular and Molecular Cardiology (2003-2005). Dr. Taubman is a member of the American Heart Association, the American Society of Hypertension, the Association of University Cardiologists, and the Association of American Medical Colleges. He is a Fellow, American College of Cardiology and Fellow, American College of Physicians. He is the former Editor-in-Chief, Arteriosclerosis, Thrombosis, and Vascular Biology.

Dr. Taubman is an international authority in vascular biology with research interests in tissue factor biology and chemokines. He has published widely – more than 120 articles, chapters, and books.

Research

Dr. Mark B. Taubman received his BA in Biochemistry from Columbia University and his M.D. from New York University School of Medicine. He subsequently completed a Residency in Internal Medicine and a Fellowship in Cardiovascular Diseases at the Brigham and Women's Hospital of Harvard Medical School. After 5 years on the faculty of the Brigham and Women's Hospital, he joined the Mount Sinai School of Medicine in New York, where he developed a well-funded research program in vascular biology, focusing on the regulation of pro-inflammatory and pro-thrombotic molecules in smooth muscle cells and in the arterial wall. In addition to his research program, Dr. Taubman was the Director of the Cardiology Fellowship, the Principal Investigator of an NIH training grant in Molecular Cardiology, and the Director of the Medical Scientist Training Program (MD-PhD). In 2003, Dr. Taubman moved to the University of Rochester as Chief of the Cardiology Division, and the Director of the Cardiovascular Research Institute. In 2007, Dr. Taubman was appointed Chairman of the Department of Medicine. Dr. Taubman has served as a charter member of the AICS study section of the NHLBI and the Chairman of the Research Committee of the National American Heart Association (AHA). In 2006, in recognition of his contributions to vascular biology, he received the Russell Ross Memorial Award of the Arteriosclerosis, Thrombosis, and Vascular Biology Council of the AHA. In 2007, Dr. Taubman was named Editor-in-Chief of the AHA journal, Arteriosclerosis, Thrombosis, and Vascular Biology.

Credentials

Education

1978
MD | New York University School of Medicine

Post-doctoral Training & Residency

07/01/1984 - 06/30/1989
Fellowship in Cardiology at Children's Hospital of Boston

07/01/1981 - 06/30/1983
Fellowship in Cardiovascular Disease at Brigham & Womens Hospital

07/01/1979 - 06/30/1981
Residency in Internal Medicine at Brigham & Womens Hospital

07/01/1978 - 06/30/1979
Internship in Internal Medicine at Brigham & Womens Hospital

VIEW ALL expand_more

Awards

2004
Alpha Omega Alpha

2002
Special Recognition Award, Council on Arteriosclerosis, Thrombosis, and Vascular Biology

1996
Distinguished Research Award, Department of Medicine, Mount Sinai School Of Medicine

1991 - 1995
Irma T. Hirschl Award "Isolation and characterization of genes regulating blood vessel growth

1984 - 1989
NIH Clinical Investigator Award "Vascular smooth muscle cDNA contractile protein clones" Boston Children's Hospital, Boston, MA

1983 - 1984
NIH Institutional Training Grant for Cardiovascular Research Brigham & Women's Hospital, Boston, MA

1972 - 1978
NIH Training Grant Medical Scientist Training Program, New York University School of Medicine, New York, NY

VIEW ALL expand_more

Patents

Patent Title: Treatment of Pulmonary Hypertension Using an Agent that Inhibits a Tissue Factor Pathway
Patent #: 1799243
Issue Date: Jul 15, 2015
Country: Europe
Invented By: Mark B Taubman, R. James White

Patent Title: Treatment of Pulmonary Hypertension Using An Agent that Inhibits a Tissue Factor Pathway
Patent #: FR1799243
Issue Date: Jul 15, 2015
Country: France
Invented By: Mark B Taubman, R. James White

Patent Title: Treatment of Pulmonary Hypertension Using An Agent that Inhibits a Tissue Factor Pathway
Patent #: DE1799243
Issue Date: Jul 15, 2015
Country: Germany
Invented By: Mark B Taubman, R. James White

Patent Title: Treatment of Pulmonary Hypertension Using An Agent that Inhibits a Tissue Factor Pathway
Patent #: GB1799243
Issue Date: Jul 15, 2015
Country: United Kingdom
Invented By: Mark B Taubman, R. James White

Patent Title: Treatment of Pulmonary Hypertension Using An Agent that Inhibits a Tissue Factor Pathway
Patent #: 8,563,511
Issue Date: Oct 22, 2013
Country: United States
Invented By: Mark B Taubman, R. James White

VIEW ALL expand_more

Publications

Journal Articles

3/2010
Spinelli SL, Casey AE, Pollock SJ, Gertz JM, McMillan DH, Narasipura SD, Mody NA, King MR, Maggirwar SB, Francis CW, Taubman MB, Blumberg N, Phipps RP. "Platelets and megakaryocytes contain functional nuclear factor-kappaB." Arteriosclerosis, thrombosis, and vascular biology.. 2010 Mar; 30(3):591-8. Epub 2009 Dec 30.

12/2009
Blumberg N, Spinelli SL, Francis CW, Taubman MB, Phipps RP. "The platelet as an immune cell-CD40 ligand and transfusion immunomodulation." Immunologic research.. 2009 Dec; 45(2-3):251-60. Epub 2009 Jan 29.

11/2009
Bernard JJ, Seweryniak KE, Koniski AD, Spinelli SL, Blumberg N, Francis CW, Taubman MB, Palis J, Phipps RP. "Foxp3 regulates megakaryopoiesis and platelet function." Arteriosclerosis, thrombosis, and vascular biology.. 2009 Nov; 29(11):1874-82. Epub 2009 Aug 06.

Books & Chapters

2003
Chapter Title: Interactions of Coagulation and Fibrinolytic Proteins with the Vessel wall
Book Title: Thrombosis and Hemorrhage
Author List: Taubman, M.B
Published By: Lippincott Williams and Wilkins 2003 in Philadelphia, PA

2002
Chapter Title: General Techniques in Molecular Cardiology
Book Title: Textbook of Cardiovascular Medicine, 2nd Edition
Author List: Lieb, M.E., and Taubman, M.B
Published By: Lippincott-Raven Publishers 2002 in Philadelphia, PA

2001
Chapter Title: Thrombosis, Arteriosclerosis, and Coronary Artery Disease
Book Title: Williams Hematology
Author List: Taubman, M.B
Published By: McGraw Hill 2001 in NY

VIEW ALL PUBLICATIONS

Reviews

At URMC, we believe that patients should be empowered to make the right decisions regarding their personal healthcare. To do so, transparency is critical. URMC partners with Press Ganey, to survey our patients about all aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying star ratings for our providers along with anonymous patient comments on our website. This will help you make better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used to generate this vital information.